My bookmarksSign up free
Source

Commission Delegated Regulation (EU) 2022/930 of 10 March 2022 supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council by specifying fees relating to the supervision by the European Securities Markets Authority of data reporting service providers

Commission Delegated Regulation (EU) 2022/930 of 10 March 2022 supplementing Regulation (EU) No 600/2014 of the European Parliament and of the Council by specifying fees relating to the supervision by the European Securities Markets Authority of data reporting service providers

Delegated Regulation (EU) 2022/930 · Regulation · 13 articles

In forceLast amended 2025-09-22

Version history

  1. Superseded version
  2. In force

Data as of 2026-11-02 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Scope

Article 1

Open ↗

This Delegated Regulation shall apply to ‘data reporting services providers’ (or ‘DRSPs’), as defined in Article 2(1), point (36a), of Regulation (EU) No 600/2014, that are subject to ESMA supervision.

Recovery of supervisory costs in full

Article 1a

Open ↗

The fees charged to DRSPs shall cover: (a)  all direct and indirect costs relating to the authorisation and supervision of DRSPs by ESMA in accordance with Regulation (EU) No 600/2014; (b)  all costs for the reimbursement of competent authorities that have carried out work pursuant to Regulation (EU) No 600/2014, in particular as a result of any delegation of tasks in accordance with Article 38o of that Regulation.

Application and authorisation fees

Article 2

Open ↗

Where a DRSP applies for authorisation to provide data reporting services it shall pay: (a)  for APAs and ARMs an application fee of EUR 20 000 for the first application and EUR 10 000 for each following application for authorisation of additional data reporting services; (b)  for APAs and ARMs an authorisation fee of EUR 80 000 for the first authorisation and EUR 40 000 for each following authorisation of additional data reporting services; (c)  for CTPs an authorisation fee of EUR 100 000 for the first authorisation and EUR 50 000 for each following authorisation of additional data reporting services.

Annual supervisory fees for APAs and ARMs

Article 3

Open ↗

1.   APAs and ARMs which are subject to ESMA supervision shall be charged an annual supervisory fee. 2.   The total annual supervisory fee and the annual supervisory fee for a given APA or ARM shall be calculated as follows: (a)  the total annual supervisory fee for a given year ( n ) shall be the estimate of expenditure relating to the supervision of APAs’ and ARMs’ activities under Regulation (EU) No 600/2014 as included in ESMA’s budget for that year; (b)  an APA or ARM annual supervisory fee for a given year ( n ) shall be the total annual supervisory fee determined pursuant to point (a) divided between all APAs and ARMs authorised in year ( n ), in proportion to their applicable turnover calculated pursuant to Article 4. 3.   In no case shall an APA or ARM authorised by ESMA pay an annual supervisory fee of less than EUR 30 000 . An APA or ARM that is subject to minimum supervisory fees for more than one data reporting service shall pay the minimum supervisory fee for each service provided. 4.   By way of derogation from paragraphs 2 and 3, and without prejudice to Article 2, the first-year fee for APAs and ARMs shall be equal to the amount of the authorisation fee referred to in Article 2(1), point (b), multiplied by a factor that is equal to the days between authorisation and the end of the year divided by the total number of days in that year. The first-year annual supervisory fee shall therefore be calculated as follows: DRSP first-year fee = Authorisation fee × Coefficient Coefficient = An APA or ARM that is authorised during the month of December shall not pay the first-year annual supervisory fee. 5.   By way of derogation from paragraphs 2 and 3, where the reassessment referred to in Article 1(3) of Commission Delegated Regulation (EU) 2022/466 ( 1 ) results in the derogation of ESMA supervision of an APA or ARM, the annual supervisory fee for the year in which the derogation applies shall be calculated solely for the five months of that year during which ESMA continues to be the supervisor of the APA or ARM in accordance with Article 1(4) of Delegated Regulation (EU) 2022/466. 6.   By way of derogation from paragraphs 2 and 3, where the reassessment referred to in Article 1(3) of Delegated Regulation (EU) 2022/466 results in ESMA supervision of an APA or ARM, the annual supervisory fee for the year in which ESMA supervision starts to apply shall be calculated solely for the seven months of that year during which ESMA is the supervisor of the APA or ARM in accordance with Article 1(4) of Delegated Regulation (EU) 2022/466.

Annual supervisory fees for CTPs

Article 3a

Open ↗

1.   A CTP which is subject to ESMA supervision shall be charged an annual supervisory fee. 2.   The total annual supervisory fee and the annual supervisory fee for each individual CTP, shall be calculated as follows: (a)  the total annual supervisory fee for a given year ( n ) shall be the estimate of expenditure relating to the supervision of the CTPs’ activities under Regulation (EU) No 600/2014 as included in ESMA’s budget for that year; (b)  the annual supervisory fee for a specific CTP for a given year ( n ) shall be the total annual supervisory fee for all CTPs calculated in accordance with point (a) divided between all CTPs authorised in year ( n ), in proportion to their applicable turnover calculated in accordance with Article 4. 3.   By way of derogation from paragraph 2, where a CTP becomes operational before 1 July of a given year ( n ), the annual supervisory fee for that CTP for years ( n ) and ( n +1) shall be calculated as follows: (a)  for year ( n ), paragraphs 4 and 5 shall apply; (b)  for year ( n +1), the annual supervisory fee shall be EUR 400 000 . By way of derogation from paragraph 2, where a CTP becomes operational on or after 1 July of a given year ( n ), the annual supervisory fee for years ( n ), ( n +1) and ( n +2) shall be calculated as follows: (a)  for year ( n ), paragraphs 4 and 5 shall apply; (b)  for years ( n +1) and ( n +2), the annual supervisory fee shall be EUR 400 000 for each year. A CTP shall be deemed to become operational on the day of the authorisation granted by ESMA pursuant to Article 27db of Regulation (EU) No 600/2014 or on the day following the expiry of the transition period referred to in Article 27db(4) of Regulation (EU) No 600/2014, where that transition period is granted by ESMA. 4.   The annual supervisory fee for year ( n ) referred to in paragraph 3 shall be equal to the amount of the annual supervisory fee of EUR 400 000 multiplied by a factor that is equal to the days between the day when a CTP becomes operational and the end of year ( n ) divided by the total number of days in that year. The annual supervisory fee shall therefore be calculated as follows: CTP fee for the year ( n ) = EUR 400 000 × Coefficient Coefficient = 5.   Without prejudice to Article 2, where ESMA has granted a CTP a transition period pursuant to Article 27db(4) of Regulation (EU) No 600/2014, the annual supervisory fee for year ( n ) shall also include a fee for the days between the day of the authorisation and the day when a CTP becomes operational. That fee shall be equal to the amount of the authorisation fee referred to in Article 2, point (c), multiplied by a factor that is equal to the days between the day of the authorisation and the day when a CTP becomes operational divided by the total number of days in year ( n ). That fee shall therefore be calculated as follows: CTP fee for the days between the authorisation and the day when a CTP becomes operational = Authorisation fee × Coefficient Coefficient= 6.   By way of derogation from paragraph 2, where the annual supervisory fee for at least one CTP is calculated in accordance with paragraph 3 and the annual supervisory fee for at least one other CTP is not calculated in accordance with that paragraph, the annual supervisory fee for that other CTP or those other CTPs shall be calculated as follows: (a)  the total annual supervisory fee for a given year ( n ) shall be the estimate of expenditure relating to the supervision of activities under Regulation (EU) No 600/2014 of all CTPs whose annual supervisory fees are not calculated in accordance with paragraph 3, as included in ESMA’s budget for that year; (b)  the annual supervisory fee for a specific CTP for a given year ( n ) shall be the total annual supervisory fee for all CTPs calculated in accordance with point (a) divided between all CTPs authorised in year ( n ) whose annual supervisory fees are not calculated in accordance with paragraph 3, in proportion to their applicable turnover calculated in accordance with Article 4.

Applicable turnover

Article 4

Open ↗

1.   DRSPs shall keep audited accounts for the purposes of this Regulation which distinguish between at least the following: (a)  revenues generated from ARM services; (b)  revenues generated from APA services; (c)  revenues generated from ancillary services to ARM activities; (d)  revenues generated from ancillary services to APA activities; (e)  revenues generated from CTP services; (f)  revenues generated from ancillary services to CTP services. 2.   The applicable turnover of a DRSP for a given year ( n ) shall be the sum of: (a)  its revenues generated from the core functions of the provision of ARM, APA or CTP services on the basis of the audited accounts of the year ( n -2), or, where those audited accounts are not yet available of the year prior to that ( n -3) and (b)  its applicable revenues from ancillary services on the basis of audited accounts of the year ( n -2), or, where those audited accounts are not yet available of the year prior to that ( n -3), divided by the sum of: (c)  the total revenues of all authorised ARMs, APAs or CTPs generated from core functions of provision of ARM, APA or CTP services on the basis of the audited account during the year ( n -2), or, where those audited accounts are not yet available of the year prior to that ( n -3) and (d)  the total applicable revenues from ancillary services of all ARMs, APAs or CTPs on the basis of audited accounts during the year ( n -2), or, where those audited accounts are not yet available of the year prior to that ( n -3). 3.   Where the data reporting services provider did not operate during the full year (n-2), its applicable turnover shall be estimated according to the formula set out in paragraph 2 by extrapolating for the data reporting services provider the values calculated for the number of months during which the data reporting services provider operated in year (n-2) to the whole year (n-2). 4.   DRSPs shall provide ESMA, on an annual basis, with audited accounts as referred to in paragraph 1. The documents shall be submitted to ESMA by electronic means no later than 30 September each year (n-1). If a DRSP authorised after 30 September, it shall provide the figures immediately upon authorisation and by end of the year of authorisation. 5.   Where the revenues referred to in paragraph 1 are reported in a currency other than the euro, ESMA shall convert those revenues into euro using the average euro foreign exchange rate applicable to the period during which the revenues were recorded. For that purpose, ESMA shall use the euro foreign exchange reference rate published by the European Central Bank.

General payment modalities

Article 5

Open ↗

1.   All fees shall be payable in euro. They shall be paid as specified in Articles 6 and 7. 2.   Any late payments shall incur the default interest laid down in Article 99 of Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council ( 2 ).

Payment of application and authorisation fees

Article 6

Open ↗

1.   The fees for application, authorisation or extension of authorisation shall be due at the time the DRSP applies and shall be paid in full within 30 days from the date of issuance of ESMA’s invoice. 2.   When a DRSP decides to withdraw its application for authorisation before ESMA adopts its reasoned decision to authorise or refuse authorisation, the application or authorisation fees shall not be reimbursed.

Payment of annual supervisory fees

Article 7

Open ↗

1.   The annual supervisory fee referred to in Article 3 shall be due at the beginning of each calendar year and paid in full to ESMA in the first three months of that year. ESMA shall submit an invoice specifying the full amount of the supervisory fee at the latest thirty days before the final payment date. The fees shall be calculated on the basis of the latest available information for annual fees. 2.   When a DRSP decides to withdraw its authorisation, the annual supervisory fee shall not be reimbursed.

Reimbursement of national competent authorities

Article 8

Open ↗

1.   In case of a delegation of tasks by ESMA to national competent authorities, the national competent authority shall not recover costs incurred while carrying out supervisory tasks delegated by ESMA directly from the DRSP. 2.   ESMA shall reimburse a competent authority for the actual costs incurred as a result of work carried out pursuant to Regulation (EU) No 600/2014, in particular as a result of any delegation of tasks pursuant to Article 38o of Regulation (EU) No 600/2014. 3.   ESMA shall ensure that the costs to be reimbursed to national competent authorities fulfil the following conditions: (a)  they should be previously agreed between ESMA and the NCA; (b)  they should be proportionate to the turnover of the relevant DRSP; and (c)  they should not be greater than the total amount of supervisory fees paid by the relevant DRSP. 4.   Any delegation of tasks by ESMA to national competent authorities shall be determined on an independent basis, may be revoked at any time and shall not impact the amount of fees charged to a particular DRSP.

Transitional provision for 2022

Article 9

Open ↗

1.   For the purposes of the calculation of the annual supervisory fee applicable to DRSPs under ESMA supervision for the year 2022, ESMA shall collect a fixed fee, based on the following calculations: (a)  EUR 350 000 for APAs that published transactions which accounted for more than 10 % of the total number of published transactions of all authorised APAs, either for equity or non-equity instruments, in the first 6 months of 2021, as reported by the competent authority concerned; (b)  EUR 50 000 for APAs that published transactions which accounted for less than 10 % of the total number of published transactions of all authorised APAs, either for equity or non-equity instruments, in the first 6 months of 2021, as reported by the competent authority concerned; (c)  EUR 650 000 for ARMs that submitted transaction reports to the relevant competent authority which accounted for more than 10 % of the total number of transaction reports submitted to competent authorities by all authorised ARMs in the first 6 months of 2021, as reported by the competent authority concerned; (d)  EUR 50 000 for ARMs that submitted transaction reports to the relevant competent authority which accounted for less than 10 % of the total number of transaction reports submitted to competent authorities by all authorised ARMs in the first 6 months of 2021, as reported by the competent authority concerned. 2.   ESMA shall provide the APAs and ARMs concerned with an invoice specifying the full amount of the fees for 2022 as soon as practically possible after this Regulation has started to apply, and at the latest thirty days before the final payment date.

Transitional provision for 2023

Article 10

Open ↗

1.   DRSPs supervised by ESMA as of 1 January 2023 shall be charged an annual supervisory fee for 2023 calculated in accordance with Article 3. However, for the purposes of Article 4(2), the applicable turnover of DRSPs shall be calculated in accordance with paragraph 2. 2.   For the purposes of paragraph 1, the applicable turnover of a DRSP shall be the sum of: (a)  the DRSP’s revenues generated from the core functions of the provision of ARM or APA services in the first 6 months of 2022 and (b)  the DRSP’s revenues generated from ancillary services to ARM or APA activities in the first 6 months of 2022, divided by the sum of: (c)  the total revenues of all authorised ARMs or APAs generated from core functions of provision of ARM or APA services in the first 6 months of 2022 and (d)  the total revenues generated from ancillary services to ARM or APA activities of all ARMs or APAs in the first 6 months of 2022. DRSPs shall, by 30 September 2022, inform ESMA about the amount of revenues generated from the core functions of the provision of ARM or APA services in the first 6 months of 2022 and about the amount of the revenues from ancillary services to ARM or APA activities in the first 6 months of 2022. 3.   As soon as the audited accounts for the year 2022 become available, the DRSPs referred to in paragraph 1 shall immediately report those audited accounts to ESMA in accordance with Article 4(1). 4.   ESMA shall calculate whether there is any difference between the annual supervisory fee for 2023 paid by the DRSP in accordance with paragraph 2 and the annual supervisory fee due for 2023 calculated on the basis of the audited accounts received in accordance with paragraph 3. 5.   ESMA shall provide the DRSPs a first invoice specifying the amount of the supervisory fee for 2023 as referred to in paragraph 2 at the latest thirty days before the final payment date. When the information referred to in paragraph 3 is available for all DRSPs, ESMA shall provide the DRSPs a second invoice specifying the final amount of the supervisory fee for 2023 based on the calculation referred to in paragraph 4. ESMA shall provide the DRSPs that invoice at the latest thirty days before the final payment date.

Entry into force and date of application

Article 11

Open ↗

This Regulation shall enter into force and apply on the third day following that of its publication in the Official Journal of the European Union .

Other acts of the same type
Commission Implementing Regulation (EU) 2023/691 of 22 March 2023 entering a name in the register of protected designations of origin and protected geographical indications (‘Komiški rogač’ (PGI))Council Implementing Regulation (EU) 2023/645 of 20 March 2023 implementing Regulation (EU) No 359/2011 concerning restrictive measures directed against certain persons, entities and bodies in view of the situation in IranCommission Regulation (EU) 2023/648 of 20 March 2023 authorising a health claim made on foods and referring to the reduction of disease risk (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/649 of 20 March 2023 concerning the authorisation of L-arginine produced by Corynebacterium glutamicum CGMCC 20516 as a feed additive for all animal species (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/650 of 20 March 2023 concerning the authorisation of a preparation of carvacrol, thymol, D-carvone, methyl salicylate and L-menthol as a feed additive for turkeys for fattening, turkeys reared for breeding, minor poultry species for fattening and minor poultry species reared for breeding (holder of authorisation: Biomin GmbH) (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/651 of 20 March 2023 concerning the authorisation of riboflavin (vitamin B2) produced by Bacillus subtilis KCCM 10445 and a preparation of riboflavin produced by Bacillus subtilis KCCM 10445 as feed additives for all animal species (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/652 of 20 March 2023 authorising the placing on the market of roasted and popped kernels from the seeds of Euryale ferox Salisb. (makhana) as a traditional food from a third country under Regulation (EU) 2015/2283 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) 2017/2470 (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/689 of 20 March 2023 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances Bacillus subtilis (Cohn 1872) strain QST 713, Bacillus thuringiensis subsp. Aizawai strains ABTS-1857 and GC-91, Bacillus thuringiensis subsp. Israeliensis (serotype H-14) strain AM65-52, Bacillus thuringiensis subsp. Kurstaki strains ABTS 351, PB 54, SA 11, SA12 and EG 2348, Beauveria bassiana strains ATCC 74040 and GHA, clodinafop, Cydia pomonella Granulovirus (CpGV), cyprodinil, dichlorprop-P, fenpyroximate, fosetyl, malathion, mepanipyrim, metconazole, metrafenone, pirimicarb, pyridaben, pyrimethanil, rimsulfuron, spinosad, Trichoderma asperellum (formerly T. harzianum) strains ICC012, T25 and TV1, Trichoderma atroviride (formerly T. harzianum) strain T11, Trichoderma gamsii (formerly T. viride) strain ICC080, Trichoderma harzianum strains T-22 and ITEM 908, triclopyr, trinexapac, triticonazole and ziram (Text with EEA relevance)Commission Implementing Regulation (EU) 2023/708 of 20 March 2023 granting a Union authorisation for the biocidal product family ‘HYPO-CHLOR Product Family’ in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (Text with EEA relevance)Commission Delegated Regulation (EU) 2023/1028 of 20 March 2023 amending Regulation (EU) No 748/2012 as regards the definition of complex motor-powered aircraft and correcting that RegulationCommission Implementing Regulation (EU) 2023/608 of 17 March 2023 amending Implementing Regulations (EU) 2020/761 and (EU) No 2020/1988 as regards the management system of some tariff quotas following the agreement between the European Union and New Zealand as a consequence of the United Kingdom’s withdrawal from the European UnionCommission Implementing Regulation (EU) 2023/611 of 17 March 2023 amending Regulation (EC) No 88/97 on the authorisation of the exemption of imports of certain bicycle parts originating in the People’s Republic of China from the extension by Council Regulation (EC) No 71/97 of the anti-dumping duty imposed by Council Regulation (EEC) No 2474/93

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next